104.395  -1.085 (-1.03%)		01-30 15:47
Open: 105.17 High: 105.89 Volume: 924,049		Pre. Close: 105.48 Low: 103.52 Market Cap: 4,614(M)

Short term
Mid term
Targets	6-month :	136.72	1-year :	148.9
Resists	First :	117.05	Second :	127.48
Pivot price	104.75
Supports	First :	100.18	Second :	83.34
MAs	MA(5) :	104.72	MA(20) :	108.97
	MA(100) :	119.33	MA(250) :	126.52
MACD	MACD :	-4.1	Signal :	-4.2
%K %D	K(14,3) :	28.2	D(3) :	22.7
RSI	RSI(14): 37.8
52-week	High :	180.58	Low :	100.18

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ TFX ] has closed above bottom band by 44.0%. Bollinger Bands are 43.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	105.79 - 106.16	106.16 - 106.5
Low:	101.89 - 102.36	102.36 - 102.79
Close:	104.72 - 105.39	105.39 - 106

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Fri, 30 Jan 2026
Needham & Company LLC Cuts Earnings Estimates for Teleflex - MarketBeat

Thu, 29 Jan 2026
Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Tue, 27 Jan 2026
Expert Outlook: Teleflex Through The Eyes Of 6 Analysts - Teleflex (NYSE:TFX) - Benzinga

Tue, 27 Jan 2026
Needham Upgrades Teleflex (TFX) - Nasdaq

Tue, 27 Jan 2026
Teleflex Incorporated (TFX): Investor Outlook Highlights Potential 26.97% Upside - DirectorsTalk Interviews

Mon, 26 Jan 2026
2026-01-26 | Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:TFX | Press Release - Stockhouse

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	44 (M)
Shares Float	42 (M)
Held by Insiders	0.3 (%)
Held by Institutions	108 (%)
Shares Short	1,740 (K)
Shares Short P.Month	2,030 (K)

EPS	-7.18
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	86.48
Profit Margin	-10.3 %
Operating Margin	12.3 %
Return on Assets (ttm)	4.9 %
Return on Equity (ttm)	-8 %
Qtrly Rev. Growth	19.3 %
Gross Profit (p.s.)	38.92
Sales Per Share	72.18
EBITDA (p.s.)	20.13
Qtrly Earnings Growth	0 %
Operating Cash Flow	391 (M)
Levered Free Cash Flow	243 (M)

PE Ratio	-14.52
PEG Ratio	0
Price to Book value	1.2
Price to Sales	1.44
Price to Cash Flow	11.76

Dividend	0.34
Forward Dividend	0
Dividend Yield	0.3%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.